MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas

Journal of Cellular Biochemistry

Volumn 114, Issue 7, 2013, Pages 1464-1473

  Wang, Yu Quan ^a   Guo, Ren De ^b   Guo, Rui Meng ^a   Sheng, Wei ^a   Yin, Li Rong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

CELL GROWTH; CHEMORESISTANCE; microRNA; miR 182; OVARIAN CARCINOMA; PDCD4

Indexed keywords

MICRORNA 182; PACLITAXEL; PROGRAMMED CELL DEATH 4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER GROWTH; CANCER RESISTANCE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MIGRATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR INVASION; UPREGULATION; WOUND HEALING;

APOPTOSIS REGULATORY PROTEINS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; RNA-BINDING PROTEINS; WOUND HEALING;

EID: 84877698814     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24488     Document Type: Article

References (34)

1. Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD,. 2010. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 221: 49-56.
2. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H,. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136. (Pubitemid 351485639)
3. Balbi G, Manganaro MA, Monteverde A, Landino I, Franzese C, Gioia F,. 2009. Ovarian cancer: lymph node metastases. Eur J Gynaecol Oncol 30: 289-291.
4. Bartel DP,. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT,. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752. (Pubitemid 46856245)
6. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ,. 2005. Real-time quantification of microRNAs by stem-loo p RT-PCR. Nucleic Acids Res 33: e179.
7. Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S, Colburn NH,. 1999. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96: 14037-14042.
8. Farazi TA, Spitzer JI, Morozov P, Tuschl T,. 2011. miRNAs in human cancer. J Pathol 223: 102-115.
9. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH,. 2008. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
10. Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P,. 2007. Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol 14: 195-208.
11. Greenlee RT, Hill-Harmon MB, Murray T, Thun M,. 2001. Cancer statistics, 2001. CA Cancer J Clin 51: 15-36. (Pubitemid 32166444)
12. Itani S, Kunisada T, Morimoto Y, Yoshida A, Sasaki T, Ito S, Ouchida M, Sugihara S, Shimizu K, Ozaki T,. 2012. MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). J Cancer Res Clin Oncol 138: 1501-1509.
13. Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X, Tang H,. 2012. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J 279: 1252-1260.
14. Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R, Wang TL, Shih Ie M,. 2011. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions. J Pathol 226: 421-426.
15. Kurman RJ, Shih Ie M,. 2010. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34: 433-443.
16. Lankat-Buttgereit B, Goke R,. 2009. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 101: 309-317.
17. Lankat-Buttgereit B, Lenschen B, Schmidt H, Goke R,. 2008. The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 13: 157-164.
18. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H,. 2007. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26: 4550-4562. (Pubitemid 47039134)
19. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, Marquez RT, Auersperg N, Yu Y, Hahn WC, Mills GB, Bast RC, Jr., 2004. A genetically defined model for human ovarian cancer. Cancer Res 64: 1655-1663. (Pubitemid 38428686)
20. Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E, Wei JJ,. 2012. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J Pathol 228: 204-215.
21. Lujambio A, Lowe SW,. 2012. The microcosmos of cancer. Nature 482: 347-355.
22. Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, Muschel RJ, Beech J, Kulshrestha R, Abdelmohsen K, Weinstock DM, Gorospe M, Harris AL, Helleday T, Chowdhury D,. 2011. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 41: 210-220.
23. Nieves-Alicea R, Colburn NH, Simeone AM, Tari AM,. 2009. Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression. Breast Cancer Res Treat 114: 203-209.
24. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E,. 2009. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 106: 1814-1819.
25. Stittrich AB, Haftmann C, Sgouroudis E, Kuhl AA, Hegazy AN, Panse I, Riedel R, Flossdorf M, Dong J, Fuhrmann F, Heinz GA, Fang Z, Li N, Bissels U, Hatam F, Jahn A, Hammoud B, Matz M, Schulze FM, Baumgrass R, Bosio A, Mollenkopf HJ, Grun J, Thiel A, Chen W, Hofer T, Loddenkemper C, Lohning M, Chang HD, Rajewsky N, Radbruch A, Mashreghi MF,. 2010. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 11: 1057-1062.
26. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K,. 2009. Modulation of microRNA processing by p53. Nature 460: 529-533.
27. Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, Cheung AN, Chan KK, Ngan HY,. 2009a. Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol Cancer 8: 70.
28. Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ, Zhu FL, Wang Q, Gao Q, Ma CH, Sun WS, Fu QZ, Chen YH, Zhang LN,. 2009b. PDCD4 inhibits the malignant phenotype of ovarian cancer cells. Cancer Sci 100: 1408-1413.
29. Wei N, Liu SS, Chan KK, Ngan HY,. 2012. Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer. PLoS ONE 7: e30311.
30. Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL, Colburn NH,. 2001. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20: 669-676. (Pubitemid 32179335)
31. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH,. 2003. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23: 26-37. (Pubitemid 36008498)
32. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH, Colburn NH,. 2006. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306. (Pubitemid 43202557)
33. Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA, Fan I, Bradley L, Shaw PA, Narod SA,. 2011. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121: 353-357.
34. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY,. 2008. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359. (Pubitemid 351333899)